| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.7 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.06 | 0.7 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |